Biocomposites announces two new Phase II clinical trials of STIMULAN VG - a calcium matrix antibiotic carrier mixed with vancomycin and gentamicin - in the U.S.

BLADE-VG2 trial will evaluate the safety and efficacy of STIMULAN VG to treat diabetic foot osteomyelitisBLADE-OPU2 will evaluate the safety and efficacy of STIMULAN VG to treat stage IV pressure ulcersView original content:https://www.prnewswire.co.uk/news-releases/biocomposites-announces-two-new-phase-ii-clinical-trials-of-stimulan-vg---a-calcium-matrix-antibiotic-carrier-mixed-with-vancomycin-and-gentamicin--in-the-us-302054936.html

en | boerse | 67931546 |